(Q36150458)

12 August 2017

1 reference

title

Development of cancer vaccines to activate cytotoxic T lymphocytes (English)

1 reference

12 August 2017

Durrant LG

1

1 reference

12 August 2017

Ramage JM

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

Expert Opinion on Biological Therapy

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

555-563

1 reference

A new era for cancer immunotherapy based on the genes that encode cancer antigens

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Concomitant helper response rescues otherwise low avidity CD8+ memory CTLs to become efficient effectors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Selective induction of high avidity CTL by altering the balance of signals from APC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Phagosomes are competent organelles for antigen cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4+ and CD8+ T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Strategies for designing and optimizing new generation vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

The use of HLA class I tetramers to design a vaccination strategy for melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

The first 1000 dendritic cell vaccinees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Induction of antigen cross-presentation by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

A Novel Human Cancer Vaccine Elicits Cellular Responses to the Tumor-Associated Antigen, Human Chorionic Gonadotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Induction of delayed hypersensitivity to human tumor cells with a human monoclonal anti-idiotypic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Immunotherapy for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

A novel CEA vaccine stimulates T cell proliferation, gammaIFN secretion and CEA specific CTL responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Activation of CD40 in cervical carcinoma cells facilitates CTL responses and augments chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

Fusion induces tumour rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.555

21 January 2018

Identifiers

DOI

10.1517/14712598.5.4.555

1 reference

12 August 2017

1 reference